Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

PLx Pharma Inc. (PLXP)

0.3321   -0.018 (-5.11%) 11-28 11:09
Open: 0.34 Pre. Close: 0.35
High: 0.3501 Low: 0.3321
Volume: 75,294 Market Cap: 10(M)

Technical analysis

as of: 2022-11-28 10:51:28 AM
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 0.63     One year: 0.81
Support: Support1: 0.3    Support2: 0.24
Resistance: Resistance1: 0.54    Resistance2: 0.69
Pivot: 0.41
Moving Average: MA(5): 0.34     MA(20): 0.46
MA(100): 1.06     MA(250): 3.18
MACD: MACD(12,26): -0.1     Signal(9): -0.1
Stochastic oscillator: %K(14,3): 12.5     %D(3): 12.9
RSI: RSI(14): 30.5
52-week: High: 10.37  Low: 0.3
Average Vol(K): 3-Month: 279 (K)  10-Days: 371 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ PLXP ] has closed above bottom band by 32.0%. Bollinger Bands are 30.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.37 - 0.37 0.37 - 0.37
Low: 0.34 - 0.34 0.34 - 0.34
Close: 0.35 - 0.35 0.35 - 0.35

Company Description

PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other aspirin and non-steroidal anti-inflammatory drug products; and Vazalore 81 mg liquid-filled aspirin capsules. Its product pipeline also includes PL1200 Ibuprofen 200 mg; and PL1100 Ibuprofen 400 mg, which are in Phase I clinical stage for pain, inflammation, and fever. The company sells its products through drugstores, mass merchandisers, grocery stores, and e-commerce channels. PLx Pharma Inc. was incorporated in 2002 and is headquartered in Sparta, New Jersey.

Headline News

Mon, 28 Nov 2022
Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday - InvestorPlace

Fri, 11 Nov 2022
PLx Pharma Earnings Beat, Revenue Misses In Q3 By -

Fri, 11 Nov 2022
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.10% By -

Fri, 11 Nov 2022
PLx Pharma (PLXP) Q3 2022 Earnings Call Transcript - Seeking Alpha

Thu, 10 Nov 2022
Pre-Market Earnings Report for November 11, 2022 : AQN, ERJ, ORLA, DDL, RGF, IMV, CMMB, PLXP, STRR, CRKN - Nasdaq

Thu, 10 Nov 2022
Earnings Preview: PLx Pharma - PLx Pharma (NASDAQ:PLXP) - Benzinga

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Drug Manufacturers—Specialty & Generic
Shares Out. 0 (M)
Shares Float 29 (M)
% Held by Insiders 2.07e+007 (%)
% Held by Institutions 15.3 (%)
Shares Short 414 (K)
Shares Short P.Month 0 (K)

Stock Financials

EPS -6.431e+007
EPS Est Next Qtl -0.47
EPS Est This Year -1.62
EPS Est Next Year -1.83
Book Value (p.s.) 0
Profit Margin (%) 0
Operating Margin (%) -1
Return on Assets (ttm) 417.7
Return on Equity (ttm) -64.4
Qtrly Rev. Growth 4.54e+006
Gross Profit (p.s.) 0.11
Sales Per Share 0.36
EBITDA (p.s.) -2.18
Qtrly Earnings Growth -1.8
Operating Cash Flow 0 (M)
Levered Free Cash Flow 0 (M)

Stock Valuations

PE Ratio -0.01
PEG Ratio -0.1
Price to Book value 0
Price to Sales 0.9
Price to Cash Flow 0

Stock Dividends

Dividend 0
Forward Dividend 248000
Dividend Yield 0%
Dividend Pay Date 2017-04-19
Ex-Dividend Date Invalid DateTime.
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.